Risk of kidney failure and death associated with target-dose (vs. below-target-dose) RAS inhibitors in HFrEF, HFmrEF and HFpEF: Spline-based reassessment of subgroup findings

By afschroeder • February 23, 2026

Raman VK, Vargas JD, Moore HJ, Wu WC, Patel SS, Zhang S, Morgan CJ, Lam PH, Heidenreich PA, Lu F, Ahmed AA, Fonarow GC, Ahmed A. Risk of kidney failure and death associated with target-dose (vs. below-target-dose) RAS inhibitors in HFrEF, HFmrEF and HFpEF: Spline-based reassessment of subgroup findings. Am J Med. 2026 Feb 21:S0002-9343(26)00079-3. doi: 10.1016/j.amjmed.2026.01.035. Epub ahead of print. PMID: 41724615.

Tags: Cardiology/Epi, Publications

Initial Diuretic Strategy During Hospitalization for Heart Failure and Associated Outcomes: Insights from the TREAT-AHF Registry

Varshney AS, Ambrosy AP, Furst A, Zheng J, Bhatt AS, Lala A, Fonarow GC, Fudim M, Greene SJ, Collins SP, Testani JM, Sandhu AT. Initial[...]

Abdominal Wall Erythema as a Suspected Extracardiac Manifestation of Cardiac Allograft Rejection

Sahlool Y, Khoury F, Akhondi A. Abdominal Wall Erythema as a Suspected Extracardiac Manifestation of Cardiac Allograft Rejection. Cureus. 2026 Jul 7;18(7):e112218. doi: 10.7759/cureus.112218. PMID:[...]

Proteomic Mediators of Chronic Obstructive Pulmonary Disease Phenotypes and Coronary Artery Calcification Burden in Ever Smokers

Abbasi A, Ahmad K, Pratte KA, Moore J, DeMeo DL, Manubolu VS, Kinninger A, Tiller NB, Bowler RP, Budoff M, Casaburi R, Rossiter HB. Proteomic[...]